N.Y Time: May 18, 2024 1:06 pm

Number of serious patients in Israel declines, Charedi cities join the vaccination efforts

Number of serious patients in Israel declines, Charedi cities join the vaccination efforts

The Health Ministry shared that less than 5,000 new cases (4,922) were discovered Thursday – 6.7% of the roughly 75,000 people who were screened. This is the lowest positive rate since January 9.

The number of serious patients is also on the decline, especially among people 60 and older, many of whom have already had two doses of the Pfizer vaccine.

In total, there were 985 serious cases reported by the Health Ministry on Friday, the second day in which the number was less than 1,000.

Among those in serious condition, 63.6% are over the age of 60, 17.1% are between 50 and 59 and 9.8% are in their 40s. Moreover, there are nearly 70 serious patients in their 30s and another around 20 who are in their 20s. There are also a handful of younger patients.

The highest rate of infection among cities is in Modi’in Illit, where close to 30% of residents are or have been diagnosed with coronavirus. However, the town has also managed to vaccinate 100% of its seniors over the age of 60.

Bnei Brak has also been working hard to get its people vaccinated.

On Thursday, Sourasky Medical Center launched a mobile vaccination campaign targeted at yeshiva students. A mobile unit traveled between the city’s largest yeshivas and offered people to get the jab.

A separate campaign took place in Bnei Brak on Thursday night at which residents of the city were encouraged to come and get vaccinated and receive a portion of cholent.

The death toll stands at 5,286. Some 15 people died on Thursday.

But Health Minister Yuli Edelstein shared positive news on Friday morning: 147,000 people were vaccinated the day before, an increase from the low the country had been experiencing in the last week or so. In total, he reported, more than 3.7 million people have received at least one dose of the coronavirus vaccine and another 2.4 million their second dose, too.